HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth Duncan Selected Research

N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate

6/2009Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
1/2007Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth Duncan Research Topics

Disease

14Neoplasms (Cancer)
02/2010 - 06/2003
7Melanoma (Melanoma, Malignant)
04/2008 - 07/2003
6Breast Neoplasms (Breast Cancer)
06/2009 - 01/2004
3Wounds and Injuries (Trauma)
06/2011 - 09/2008
2Autolysis
05/2009 - 06/2008
2Hepatocellular Carcinoma (Hepatoma)
05/2007 - 10/2004
2Hemolysis
05/2004 - 01/2004
1Macular Degeneration (Age-Related Maculopathy)
08/2011
1Rheumatoid Arthritis
08/2011
1Pathologic Processes
01/2011
1Arthritis (Polyarthritis)
11/2009
1Multiple Sclerosis
11/2009
1Virus Diseases (Viral Diseases)
11/2009
1Colorectal Neoplasms (Colorectal Cancer)
06/2009
1Breast Cancer 3
06/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2008
1Glaucoma
08/2004
1Cicatrix (Scar)
08/2004

Drug/Important Bio-Agent (IBA)

13PolymersIBA
01/2011 - 06/2003
8hydroxypropyl methacrylateIBA
02/2010 - 07/2003
6DextrinsIBA
06/2011 - 04/2008
5Pharmaceutical PreparationsIBA
02/2010 - 06/2003
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009 - 11/2003
4EnzymesIBA
06/2010 - 07/2003
4alpha-AmylasesIBA
06/2010 - 04/2008
4Proteins (Proteins, Gene)FDA Link
02/2010 - 06/2003
3Epidermal Growth Factor (EGF)IBA
06/2011 - 06/2009
3Hormones (Hormone)IBA
11/2009 - 06/2005
2Antineoplastic Agents (Antineoplastics)IBA
08/2011 - 11/2003
2N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009 - 01/2007
2AnthracyclinesIBA
06/2009 - 07/2005
2TrypsinIBA
05/2009 - 06/2008
2Biological ProductsIBA
09/2008 - 04/2008
2Dendrimers (Dendrons)IBA
02/2007 - 08/2004
2ProdrugsIBA
10/2004 - 07/2003
2polyacetalIBA
01/2004 - 11/2003
1AmylasesFDA Link
06/2011
1Peptides (Polypeptides)IBA
01/2011
1Pancreatic Elastase (Elastase)IBA
06/2010
1LigandsIBA
02/2010
1Phospholipases (Phospholipase)IBA
06/2009
1CrotoxinIBA
06/2009
1Ethylene Glycol (Monoethylene Glycol)IBA
05/2009
1methacrylamideIBA
05/2009
1monomethoxypolyethylene glycol (MPEG)IBA
05/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2008
1Melanins (Melanin)IBA
04/2008
1Melanocyte-Stimulating Hormones (MSH)IBA
04/2008
1Asialoglycoprotein ReceptorIBA
05/2007
1GalactosamineIBA
05/2007
1Peptide Hydrolases (Proteases)FDA Link
01/2007
1Sulfhydryl Compounds (Thiols)IBA
01/2007
1HPMA copolymer-Dox-AGMIBA
01/2007
1Aromatase (CYP19)IBA
01/2007
1Aromatase InhibitorsIBA
09/2005
1N-(2-hydroxypropyl)methacrylamideIBA
09/2005
1Indicators and Reagents (Reagents)IBA
07/2005
1LectinsIBA
10/2004
1Glucosamine (Dona)IBA
08/2004
1Phosphates (Orthophosphate)IBA
05/2004
1Citric Acid (Citrate)FDA LinkGeneric
05/2004
1Lactic Acid (Lactate)FDA LinkGeneric
05/2004
1Sulfates (Sulfates, Inorganic)IBA
05/2004
1Acetates (Acetic Acid Esters)FDA Link
05/2004
1DAQIBA
01/2004

Therapy/Procedure

13Therapeutics
06/2011 - 06/2003
1Drug Therapy (Chemotherapy)
01/2007
1Filtering Surgery
08/2004